Company Filing History:
Years Active: 2025
Title: Innovations by Dennis Molnar in the Field of Pharmacology
Introduction
Dennis Molnar is an accomplished inventor based in Hopkinton, NH (US). He has made significant contributions to the field of pharmacology, particularly in the development of polymorphic forms of medications. His work focuses on enhancing the efficacy and usability of pharmaceutical compounds.
Latest Patents
Dennis Molnar holds a patent for "Polymorphic forms of (R)-oxybutynin hydrochloride." This patent includes the preparation and characterization of three crystalline forms of (R)-oxybutynin HCl. The various polymorphic forms of (R)-oxybutynin HCl are disclosed for their potential uses in treating Obstructive Sleep Apnea (OSA). This innovation represents a significant advancement in the treatment options available for this condition.
Career Highlights
Dennis Molnar is currently associated with Apnimed, Inc., a company based in Delaware. His role at Apnimed involves leveraging his expertise in pharmacology to develop innovative solutions for sleep-related disorders. His contributions have been instrumental in advancing the company's mission to improve patient outcomes.
Collaborations
Due to space constraints, the details of Dennis Molnar's collaborations will not be included in this article.
Conclusion
Dennis Molnar's work in developing polymorphic forms of (R)-oxybutynin hydrochloride showcases his commitment to innovation in pharmacology. His contributions are paving the way for improved treatments for Obstructive Sleep Apnea, highlighting the importance of research and development in the medical field.